A superior early myocardial infarction marker: Human heart-type fatty acid-binding protein

Zeitschrift fur Kardiologie

Volumn 93, Issue 5, 2004, Pages 388-397

  Chan, C P Y ^a   Sanderson, J E ^b   Glatz, J F C ^c   Cheng, W S ^a   Hempel, A ^d   Renneberg, R ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

Author keywords

Acute myocardial infarction; Cardiac troponin I; Creatine phosphokinase; Fatty acid binding protein; Receiver operating characteristic

Indexed keywords

CREATINE KINASE; FATTY ACID BINDING PROTEIN; TROPONIN C;

ADULT; ARTICLE; CLASSIFICATION; ENZYME ASSAY; FEMALE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; IMMUNOCHEMISTRY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MONITORING; PERFORMANCE; SYMPTOM; THORAX PAIN;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARRIER PROTEINS; CREATINE KINASE; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TROPONIN I;

EID: 2942576318     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-004-0080-6     Document Type: Article

References (27)

1. Aartsen WM, Pelsers MM, Hermens WT, Glatz JF, Daemen MJ, Smits JF (2000) Heart fatty acid binding protein and cardiac troponin T plasma concentrations as markers for myocardial infarction after coronary artery ligation in mice. Pflugers Archiv - European Journal of Physiology 439:416-422
2. Adams J, Trent R, Rawles J (1993) Earliest electrocardiographic evidence of myocardial infarction: implications for thrombolytic treatment. The GREAT Group. British Medical Journal 307:409-413
3. Alpert JS, Thygesen K, Antman E, Bassand JP et al (2000) Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Journal of the American College of Cardiology 36:959-969
4. Bertrand ME, Simoons ML, Fox KA, Wallentin LC, Hamm CW, McFadden E, de Feyter PJ, Specchia G, Ruzyllo W (2000) Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology. European Heart Journal 21:1406-1432
5. Ghani F, Wu AH, Graff L, Petry C, Armstrong G, Prigent F, Brown M (2000) Role of heart-type fatty acid-binding protein in early detection of acute myocardial infarction. Clinical Chemistry 46:718-719
6. Glatz JFC, Haastrup B, Hermens WT et al (1997) Fatty acid-binding protein and the early detection of acute myocardial infarction: the EUROCARDI multicenter trial. Circulation 96:I-215 (abstract)
7. Glatz JFC, Kleine AH, van Nieuwenhoven FA, Hermens WT, van Dieijen-Visser MP, van der Vusse GJ (1994) Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans. British Heart Journal 71:135-140
8. Glatz JFC, van Bilsen M, Paulussen RJ, Veerkamp JH, van der Vusse GJ, Reneman RS (1988) Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochimica et Biophysica Acta 961:148-152
9. Glatz JFC, van der Voort D, Hermen WT (2002) Fatty acid-binding protein as the earliest available plasma marker of acute myocardial injury. J Clin Ligand Assay (in press)
10. Glatz JFC, van der Vusse GJ (1996) Cellular fatty acid-binding proteins: their function and physiological significance. Progress in Lipid Research 35:243-282
11. Gorski J, Hermens WT, Borawski J, Mysliwiec M, Glatz JFC (1997) Increased fatty acid-binding protein concentration in plasma of patients with chronic renal failure. Clinical Chemistry 43:193-195
12. Haastrup B, Gill S, Kristensen SR, Jorgensen PJ, Glatz JFC, Haghfelt T, Horder M (2000) Biochemical markers of ischemia for the early identification of acute myocardial infarction without St segment elevation. Cardiology 94:254-261
13. Hermens WT (1998) In Myocardial damage: early detection by novel biochemical markers. In: Kaski JC, Holt DW (eds) Mechanism of release of proteins from injured muscular tissue. Kluwer, Academic Publishers, pp 85-98
14. Kleine AH, Glatz JFC, van Nieuwenhoven FA, van der Vusse GJ (1992) Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Molecular & Cellular Biochemistry 116:155-162
15. Knowlton AA, Apstein CS, Saouf R, Brecher P (1989) Leakage of heart fatty acid binding protein with ischemia and reperfusion in the rat. Journal of Molecular & Cellular Cardiology 21:577-583
16. Knowlton AA, Burrier RE, Brecher P (1989) Rabbit heart fatty acid-binding protein. Isolation, characterization, and application of a monoclonal antibody. Circulation Research 65:981-988
17. Lee TH, Juarez G, Cook EF, Weisberg MC, Rouan GW, Brand DA, Goldman L (1991) Ruling out acute myocardial infarction. A prospective multicenter validation of a 12-hour strategy for patients at low risk. New England Journal of Medicine 324:1239-1246
18. Nayashida N, Chihara S, Tayama E, Akasu K, Kai E, Kawara T, Aoyagi S (2001) Influence of renal function on serum and urinary heart fatty acid-binding protein levels. Journal of Cardiovascular Surgery 42:735-740
19. Nielsen NE, Olsson AG, Swahn E (2000) Plasma lipoprotein particle concentrations in postmenopausal women with unstable coronary artery disease. Analysis of diagnostic accuracy using receiver operating characteristics. Journal of Internal Medicine 247:43-52
20. Okamoto F, Sohmiya K, Ohkaru Y, Kawamura K, Asayama K, Kimura H, Nishimura S, Ishii H, Sunahara N, Tanaka T (2000) Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB. Clinical Chemistry & Laboratory Medicine 38:231-238
21. Sohmiya K, Tanaka T, Tsuji R, Yoshimoto K, Nakayama Y, Hirota Y, Kawamura K, Matsunaga Y, Nishimura S, Miyazaki H (1993) Plasma and urinary heart-type cytoplasmic fatty acid-binding protein in coronary occlusion and reperfusion induced myocardial injury model. Journal of Molecular & Cellular Cardiology 25:1413-1426
22. Tanaka T, Hirota Y, Sohmiya K, Nishimura S, Kawamura K (1991) Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction. Clinical Biochemistry 24:195-201
23. Tsuji R, Tanaka T, Sohmiya K, Hirota Y, Yoshimoto K, Kinoshita K, Kusaka Y, Kawamura K, Morita H, Abe S (1993) Human heart-type cytoplasmic fatty acid-binding protein in serum and urine during hyperacute myocardial infarction. International Journal of Cardiology 41:209-217
24. Van Nieuwenhoven FA, Kleine AH, Wodzig WH, Hermens WT, Kragten HA, Maessen JG, Punt CD, Van Dieijen MP, van der Vusse GJ, Glatz JFC (1995) Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 92:2848-2854
25. Veerkamp JH, Maatman RG (1995) Cytoplasmic fatty acid-binding proteins: their structure and genes. Progress in Lipid Research 34:17-52
26. Wodzig KW, Kragten JA, Hermens WT, Glatz JFC, van Dieijen-Visser MP (1997) Estimation of myocardial infarct size from plasma myoglobin or fatty acid-binding protein. Influence of renal function. European Journal of Clinical Chemistry & Clinical Biochemistry 35:191-198
27. Wodzig KW, Pelsers MM, van der Vusse GJ, Roos W, Glatz JFC (1996) One-step enzyme-linked immunosorbent assay (ELISA) for serum fatty acid-binding protein. Annual Clinical Biochemistry 33:1-6